Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Doximity, Inc. (DOCS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
32.00+1.54 (+5.06%)
At close: 04:00PM EDT
31.00 -1.01 (-3.16%)
After hours: 04:10PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • L
    Letty
    It’s going up!
    Bullish
  • T
    Trader
    87% of companies that went public last year are trading below their IPO price. By that measure, DOCS at least is doing well. It's a great, growing, highly profitable company caught up in an awful market.

    https://www.wsj.com/articles/poor-ipo-stock-performance-weighs-further-on-new-issue-market-11664184781?mod=hp_lead_pos2
    Bullish
  • D
    Daniel C
    Its likely this stock will go below 30s as its overvalued but if you look at the upside potential this stock is a no brainer to hold for the long term. I'm patiently waiting for anything below 28-29. It currently has a strong resistance at 31+

    I do hope the market continues to tank so I can scoop up some amazing companies.
  • M
    Michael
    Once the real slide happens and most retail is under margin call status then DOCS maybe be in the low teens area. 10-15
  • M
    Mark
    What seems to be going on here is that they trash this stock during regular hours and pick up shares after hours. When I see this kind of stuff, usually bolts north within a few days. Well here is hoping!!!!
  • G
    GOP.DowJones6500
    Physicians are signing up like Hot Cake. DOCS is in infancy and I strongly think this is a last Opportunity to but below $40
  • M
    Misguided missile
    Are we on a day traders list? Stock is getting whipsawed! Up by 10% yesterday and now down 11%.
  • B
    B
    With DOCS here is what I look at: at 15% annual AVERAGE share price growth, over 10 years, it is a 4 bagger. At a measly 12% it is a 3 bagger, and at 18% it is a 5 bagger. So, they are still growing BOTH revenue and EPS, and even in a recessionary environment they are still forecasting right around 20% Revenue AND EPS. If the economy starts picking up some time next year I anticipate they would be able to sustain that for at least 2 or 3 years. Looking forward, for the PATIENT investor, this is an easy 3 bagger if not 4 or 5 in the next 10 years.

    Run the numbers yourself. Use a compound interest calculator and see that $10,000 over 10 years becomes a little over $30,000 @ 11.74%, $40,000 @ 15%, and $50,000 at 18%. I don't think this company will have too much trouble maintaining a 12-14% average clip for the 10 years. So this one is easily a 3-5 bagger. Who knows, maybe they will shock everyone and become a 10 bagger???
  • T
    Thomas
    Doximity is revising its guidance for its fiscal year ending March 31, 2023 as follows:

    Revenue between $424.0 million and $432.0 million.

    Adjusted EBITDA between $178.0 million and $186.0 million

    Anybody knows what they previously guided?
  • M
    Misguided missile
    Looks like we’re going to be disappointed. The selling started early today, it appears
  • D
    Dragan
    Very solid numbers. Should be green tomorrow. GLA.....
  • W
    Walter
    Unacceptable to reduce sales guidance. They have the market captivated and there are plenty of add on products to be developed and launched into thier base. I think managment has finally hit the point where the numbers and sales reduction demonstrate they may have issues managing and navigating this company into the future. Great customer base, great industry, plenty of product opprtunities but at this point I am unsure of this leadership.
  • S
    Sid
    Important indicators for growth👌🙏
    1. Healthcare sector is the next big thing for tech;
    2. DOCS is used by about 80% of American physicians and nurse practitioners;
    3. Over 200,000 DOCS daily dialers by physicians and nurse practitioners last quarter
    4. With so much visibility and applicability, DOCS is in pole position

    Now everything will depend on how management will leverage these awesome lead. For example:
    A. Can they increase slight cost per user
    B. Can they make patients and for that matter everyone in USA (as everyone needs a health record) get their DOCS account for a small fees
    C. Can they expand internationally
    D, can they bring Ad revenues

    This can grow insane going forward leveraging on their pole position👌🙏
    Bullish
  • K
    Kevin
    Trying to buy more in PM. Same thing happened last earnings. Tanked it to 26(?) and a month later it was 41.
  • T
    Tommy
    Who is DOCS competition in this space?
  • S
    Steve
    Another good opportunity to averaged down, my buy limit order at $36.88 went through. No brainer not to.
    Bullish
  • K
    K
    Doximity beats by $0.03, beats on revs; guides Q2 revs below consensus; guides FY23 revs below consensus
    Reports Q1 (Jun) earnings of $0.14 per share, excluding non-recurring items, $0.03 better than the S&P Capital IQ Consensus of $0.11; revenues rose 24.6% year/year to $90.6 mln vs the $89.65 mln S&P Capital IQ Consensus. Co issues downside guidance for Q2, sees Q2 revs of $99.5-100.5 mln vs. $105.03 mln S&P Capital IQ Consensus. Co issues downside guidance for FY23, sees FY23 revs of $424-432 mln vs. $455.92 mln S&P Capital IQ Consensus.
  • S
    Sid
    DOCS making huge move

    3,3 million shares traded in the first hour (2.5 million is daily average). Started the day -16% and now -6%. So, that 10% positive move with such volume tells DOCS is beginning to get its respect 👌🙏
    Bullish
  • J
    John
    lots of companies cut their next earning guidelines lower so they can beat it on earning. Microsoft does it all the time.
Advertisement
Advertisement